#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Cluster headache Marginal zone lymphoma refractory Congenital growth hormone deficiency Ventricular tachycardia Craniopharyngioma B-cell type acute leukaemia Philadelphia chromosome positive Haemolytic uraemic syndrome B-cell small lymphocytic lymphoma refractory Chronic myeloid leukaemia (in remission) Penile squamous cell carcinoma Renal cell carcinoma Prolymphocytic leukaemia Gastroenteropancreatic neuroendocrine tumour disease Chronic granulomatous disease More trials…

    Learn about Rare Diseases

    Gastrointestinal stromal tumour – Treatment IgA nephropathy Glomerulonephritis rapidly progressive – Basic Information Synovial sarcoma recurrent – Diagnostics SAPHO syndrome – Diagnostics Hairy cell leukaemia – Trials in Disease Alveolar rhabdomyosarcoma Pituitary-dependent Cushing’s syndrome – Trials in Disease Gaucher’s disease type I – Life with Disease Lymphangioma – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    FG001 Sacubitril Valsartan Ruxotemitide Vb10.16 HSP-CAR30 Seladelpar Emrusolmin Salbutamol Sulfate Ph. Eur. Ab-729 Melatonin X-396 Hhalpc Glucose Ramucirumab Pemigatinib Azelastine Hydrochloride Aavanc80-5'Hotof Warfarin Nadroparin Calcium Enlicitide Chloride More therapies…

    Learn about Your Condition

    Ehlers-Danlos syndrome Squamous cell carcinoma Leiomyosarcoma Hyperlipidaemia Lennox-Gastaut syndrome Muscular dystrophy PIK3CA-activated mutation Oesophageal achalasia Stress Dysmenorrhoea Pulmonary venous thrombosis Pneumothorax Neurogenic bladder Shock Bile duct cancer More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study on Long-Term Safety and Effects of Maralixibat for Patients with Alagille Syndrome

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Alagille syndrome
    Investigated Drugs:
    • MARALIXIBAT
    Belgium France Germany Italy The Netherlands Portugal +1

  • Study of DCC-3116 and ripretinib combination therapy in patients with advanced gastrointestinal stromal tumor (GIST)

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Gastrointestinal stromal tumour
    Investigated Drugs:
    • Dcc-3116
    • Ripretinib
    Denmark France Germany Greece Italy The Netherlands +2

  • Study on Colchicine to Reduce Heart Artery Inflammation in HIV Patients Over 50 with High Cardiovascular Risk

    Recruiting

    2 1 1
    Investigated Diseases:
    • HIV infection
    Investigated Drugs:
    • Colchicine
    Spain

  • Study on the Safety and Effects of IPN01195 in Adults with Advanced Solid Tumors

    Recruiting

    2 1 1
    Investigated Diseases:
    • Neoplasm
    Investigated Drugs:
    • IPN01195
    France Italy Spain

  • Study Comparing BMS-986393 CAR T Cell Therapy to Standard Treatments for Adults with Relapsed or Refractory Multiple Myeloma Resistant to Lenalidomide

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • ARLOCABTAGENE AUTOLEUCEL
    • Fludarabine Phosphate
    • Carfilzomib
    Austria Belgium Czechia Denmark Finland France +11

  • Study of trospium chloride and xanomeline tartrate (KarXT) in patients with psychosis associated with Alzheimer’s disease

    Recruiting

    3 1
    Investigated Diseases:
    • Psychotic disorder
    • Dementia Alzheimer’s type
    Investigated Drugs:
    • Trospium Chloride
    • Xanomeline Tartrate
    Belgium Bulgaria Croatia France Germany Greece +7
Previous Page
1 … 647 648 649 650 651 … 1,656
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!